/

Other

/

FinVector Oy

FinVector Oy

FinVector Oy

Verified Nov 2026

Other

·

Kuopio

·

Since 1993

FinVector Oy is a biopharmaceutical contract manufacturer founded in 1993 and headquartered in Kuopio, Finland. The company employs 200–500 staff and operates one of Europe's gene therapy production facilities. FinVector specializes in cGMP manufacturing of viral vectors including Adenoviral, AAV, and Lentiviral types, serving clients in biopharmaceutical development and commercialization across multiple therapeutic areas.

FinVector Oy

Verified Nov 2026

AT A GLANCE

Founded

1993

Headquarters

Kuopio

Employees

200-500

Ownership

FinVector Oy at a glance

Revenue

$10-50M

Est. band

Employees

200-500

Founded

1993

Headquarters

Kuopio

Industries

Automotive

Electric Vehicles

Construction

Medical

Industrial Equipment

Overview

FinVector Oy is a biopharmaceutical contract manufacturer founded in 1993 and headquartered in Kuopio, Finland. The company employs 200–500 staff and operates one of Europe's gene therapy production facilities. FinVector specializes in cGMP manufacturing of viral vectors including Adenoviral, AAV, and Lentiviral types, serving clients in biopharmaceutical development and commercialization across multiple therapeutic areas.

At a glance

Attribute

Detail

Founded

1993

Headquarters

Kuopio

Employees

200-500

Revenue

$10-50M (estimated)

What FinVector Oy makes

The company provides contract manufacturing and process development services for viral-based gene therapies under cGMP conditions, with cleanroom facilities.

Latest developments

Facilities

FinVector Oy is headquartered in Kuopio. Public sources also reference these locations:

Company details

FinVector is a subsidiary of Ferring Ventures S/A, part of Ferring Pharmaceuticals, and operates with a workforce drawn from over 50 nationalities. FinVector Oy was founded in 1993, has an estimated 200-500 employees, and is headquartered in Kuopio.

Frequently asked questions

What does FinVector Oy do?

FinVector Oy is a biopharmaceutical contract manufacturer founded in 1993 and headquartered in Kuopio, Finland. The company employs 200–500 staff and operates one of Europe's gene therapy production facilities. FinVector specializes in cGMP manufacturing of viral vectors including Adenoviral, AAV, and Lentiviral types, serving clients in biopharmaceutical development and commercialization across multiple therapeutic areas.

Where is FinVector Oy headquartered?

FinVector Oy is headquartered in Kuopio.

When was FinVector Oy founded?

FinVector Oy was founded in 1993.

How big is FinVector Oy?

FinVector Oy has an estimated 200-500 employees, with revenue in the $10-50M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

KuopioHeadquarters · Finland
KuopioKuopio, 70110, FinlandHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.